app

Pfizer and Akili Join Forces For Gamification of Alzheimer’s Disease

Akili Interactive Labs Inc. announced today that it has entered into an agreement with Pfizer Inc. to test the ability of Akili's mobile video game platform ("Project EVO") to detect cognitive differences in healthy elderly people at risk of developing Alzheimer's disease. To Akili's knowledge this is the first time that a large pharmaceutical company [...]

January 6th, 2017|News|

FDA Approval For Melafind

MELA Sciences MELA today announced that the U.S. Food and Drug Administration (FDA) has issued an Approvable Letter for the MelaFind(R) Pre-Market Approval (PMA) application. The company intends to work with the agency to finalize the physician and patient labeling, package insert, user's guide, training program and clinical protocol for a post-approval study in order [...]

September 27th, 2011|News|